78 related articles for article (PubMed ID: 23775185)
1. Development of anti-influenza A compounds: a pilot study.
Zheng BJ; Chan CS; Poon KM; Ng F; Ho CM; Che CM; Yuen KY
Hong Kong Med J; 2013 Jun; 19 Suppl 4():36-8. PubMed ID: 23775185
[TBL] [Abstract][Full Text] [Related]
2. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues.
Uyeki TM
Clin Infect Dis; 2009 Jul; 49(2):279-90. PubMed ID: 19522652
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a new class of antiviral compounds: camphor imine derivatives.
Sokolova AS; Yarovaya OI; Shernyukov AV; Gatilov YV; Razumova YV; Zarubaev VV; Tretiak TS; Pokrovsky AG; Kiselev OI; Salakhutdinov NF
Eur J Med Chem; 2015 Nov; 105():263-73. PubMed ID: 26498572
[TBL] [Abstract][Full Text] [Related]
4. The Madin-Darby canine kidney cell culture derived influenza A/H5N1 vaccine: a phase I trial in Taiwan.
Pan SC; Kung HC; Kao TM; Wu H; Dong SX; Hu MH; Chou AH; Chong P; Hsieh SM; Chang SC
J Microbiol Immunol Infect; 2013 Dec; 46(6):448-55. PubMed ID: 23022464
[TBL] [Abstract][Full Text] [Related]
5. Oligothiophene compounds inhibit the membrane fusion between H5N1 avian influenza virus and the endosome of host cell.
Zhu Z; Yao Z; Shen X; Chen Z; Liu X; Parquette JR; Liu S
Eur J Med Chem; 2017 Apr; 130():185-194. PubMed ID: 28246043
[TBL] [Abstract][Full Text] [Related]
6. CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry.
Liu S; Li R; Zhang R; Chan CC; Xi B; Zhu Z; Yang J; Poon VK; Zhou J; Chen M; Münch J; Kirchhoff F; Pleschka S; Haarmann T; Dietrich U; Pan C; Du L; Jiang S; Zheng B
Eur J Pharmacol; 2011 Jun; 660(2-3):460-7. PubMed ID: 21536025
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M
Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
[TBL] [Abstract][Full Text] [Related]
8. Isocyanides as Influenza A Virus Subtype H5N1 Wild-Type M2 Channel Inhibitors.
Wu S; Huang J; Gazzarrini S; He S; Chen L; Li J; Xing L; Li C; Chen L; Neochoritis CG; Liao GP; Zhou H; Dömling A; Moroni A; Wang W
ChemMedChem; 2015 Nov; 10(11):1837-45. PubMed ID: 26506405
[TBL] [Abstract][Full Text] [Related]
9. Heterocyclic compounds based on 3-(4-bromophenyl) azo-5-phenyl-2(3H)-furanone: anti-avian influenza virus (H5N1) activity.
Flefel EM; Abdel-Mageid RE; Tantawy WA; Ali MA; Amr Ael-G
Acta Pharm; 2012 Dec; 62(4):593-606. PubMed ID: 23333891
[TBL] [Abstract][Full Text] [Related]
10. D282, a non-nucleoside inhibitor of influenza virus infection that interferes with de novo pyrimidine biosynthesis.
Smee DF; Hurst BL; Day CW
Antivir Chem Chemother; 2012 Aug; 22(6):263-72. PubMed ID: 22516927
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationship study of arylsulfonamides as novel potent H5N1 inhibitors.
Yu Y; Tang Q; Xu Z; Li S; Jin M; Zhao Z; Dong C; Wu S; Zhou HB
Eur J Med Chem; 2018 Nov; 159():206-216. PubMed ID: 30292897
[TBL] [Abstract][Full Text] [Related]
12. Anti-influenza A virus activity of uridine derivatives of 2-deoxy sugars.
Krol E; Wandzik I; Gromadzka B; Nidzworski D; Rychlowska M; Matlacz M; Tyborowska J; Szewczyk B
Antiviral Res; 2013 Oct; 100(1):90-7. PubMed ID: 23911991
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of 3-O-β-chacotriosyl oleanic acid derivatives as entry inhibitors for highly pathogenic H5N1 influenza virus.
Li S; Jia X; Shen X; Wei Z; Jiang Z; Liao Y; Guo Y; Zheng X; Zhong G; Song G
Bioorg Med Chem; 2017 Aug; 25(16):4384-4396. PubMed ID: 28651913
[TBL] [Abstract][Full Text] [Related]
14. A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance.
Ehrhardt C; Hrincius ER; Korte V; Mazur I; Droebner K; Poetter A; Dreschers S; Schmolke M; Planz O; Ludwig S
Antiviral Res; 2007 Oct; 76(1):38-47. PubMed ID: 17572513
[TBL] [Abstract][Full Text] [Related]
15. Anti-H5N1 virus flavonoids from Capparis sinaica Veill.
Ibrahim AK; Youssef AI; Arafa AS; Ahmed SA
Nat Prod Res; 2013; 27(22):2149-53. PubMed ID: 23651316
[TBL] [Abstract][Full Text] [Related]
16. [Antiviral activity of phosprenyl and gamapren against infection caused by influenza a (H5N1) virus in cell culture].
Sanin AV; Deryabin PG; Narovlyansky AN; Pronin AV; Kozhevnikova TN
Vopr Virusol; 2017; 62(4):168-173. PubMed ID: 29733166
[TBL] [Abstract][Full Text] [Related]
17. Antiviral activity of acidic polysaccharides from Coccomyxa gloeobotrydiformi, a green alga, against an in vitro human influenza A virus infection.
Komatsu T; Kido N; Sugiyama T; Yokochi T
Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):1-7. PubMed ID: 22856509
[TBL] [Abstract][Full Text] [Related]
18. Anti-H5N1 virus new diglyceride ester from the Red Sea grass Thallasodendron ciliatum.
Ibrahim AK; Youssef AI; Arafa AS; Foad R; Radwan MM; Ross S; Hassanean HA; Ahmed SA
Nat Prod Res; 2013; 27(18):1625-32. PubMed ID: 23163517
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of recombinant mouse β-defensin 3 against influenza A virus in vitro and in vivo.
Jiang Y; Yang D; Li W; Wang B; Jiang Z; Li M
Antivir Chem Chemother; 2012 Aug; 22(6):255-62. PubMed ID: 22345365
[TBL] [Abstract][Full Text] [Related]
20. [3-O-β-chacotriosyl benzyl ursolate inhibits entry of H5N1 influenza virus into target cells].
Song G; Shen X; Li Y; Zheng Y; Xiong P; Liu S
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jun; 35(6):789-94. PubMed ID: 26111672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
